Cetuximab in combination with methotrexate (MTX) as first-line treatment in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A phase Ib randomized phase II study versus single agent MTX
Author(s):
Ham, J.; Meerten, E.; Fiets, E.; Mc Haaglanden, F.J.; Slingerland, M.; Graaf, W.T.A. van der; Herpen, C.M.L. van; Beerepoot, L.V.
